+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Cardiac Arrest Treatment Market by Treatment (Drug, Medical Devices), Distribution Channel (Hospitals, Independent Pharmacies) - Forecast 2024-2030

  • PDF Icon

    Report

  • 193 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5313728
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Cardiac Arrest Treatment Market size was estimated at USD 21.77 billion in 2023, USD 23.73 billion in 2024, and is expected to grow at a CAGR of 9.08% to reach USD 40.03 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cardiac Arrest Treatment Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cardiac Arrest Treatment Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cardiac Arrest Treatment Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Amgen Inc., Bayer AG, BIOTRONIK SE & CO., KG, Boston Scientific Corporation, Bristol-Myers Squibb Company, Fukuda Denshi Co., Ltd, Johnson & Johnson Services, Inc., Koninklijke Philips N.V., LivaNova PLC, Medtronic PLC, Nihon Kohden Corporation, Novartis International AG, Pfizer Inc., Stryker Corporation, and ZOLL Medical Corporation.

Market Segmentation & Coverage

This research report categorizes the Cardiac Arrest Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Treatment
    • Drug
      • Anti-Arrhythmic Drugs
      • Anticholinergic Drugs
      • Beta Blockers
      • Corticosteroids
      • Fibrinolytic Drugs
      • Vasopressors
    • Medical Devices
      • Cardiac Resynchronization Therapy
      • Defibrillators
  • Distribution Channel
    • Hospitals
    • Independent Pharmacies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Cardiac Arrest Treatment Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cardiac Arrest Treatment Market?
  3. What are the technology trends and regulatory frameworks in the Cardiac Arrest Treatment Market?
  4. What is the market share of the leading vendors in the Cardiac Arrest Treatment Market?
  5. Which modes and strategic moves are suitable for entering the Cardiac Arrest Treatment Market?

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Purchase of this report includes 1 year online access with quarterly updates

Purchase of this report includes 1 year online access with quarterly updates

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Cardiac Arrest Treatment Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of cardiac disorders worldwide
5.1.1.2. Government initiatives for cardiovascular health and wellness
5.1.1.3. Awareness related to advancements in medical devices for the treatment of cardiac arrest
5.1.2. Restraints
5.1.2.1. Expensive treatments associated with cardiac arrest
5.1.3. Opportunities
5.1.3.1. Emergence of minimally invasive procedures
5.1.3.2. Advancements in cardiac arrest treatments and procedures
5.1.4. Challenges
5.1.4.1. Lack of advanced healthcare infrastructure and skilled professionals
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Cardiac Arrest Treatment Market, by Treatment
6.1. Introduction
6.2. Drug
6.3.1. Anti-Arrhythmic Drugs
6.3.2. Anticholinergic Drugs
6.3.3. Beta Blockers
6.3.4. Corticosteroids
6.3.5. Fibrinolytic Drugs
6.3.6. Vasopressors
6.3. Medical Devices
6.4.1. Cardiac Resynchronization Therapy
6.4.2. Defibrillators
7. Cardiac Arrest Treatment Market, by Distribution Channel
7.1. Introduction
7.2. Hospitals
7.3. Independent Pharmacies
8. Americas Cardiac Arrest Treatment Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Cardiac Arrest Treatment Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Cardiac Arrest Treatment Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player
12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. Abbott Laboratories
12.1.2. Amgen Inc.
12.1.3. Bayer AG
12.1.4. BIOTRONIK SE & CO., KG
12.1.5. Boston Scientific Corporation
12.1.6. Bristol-Myers Squibb Company
12.1.7. Fukuda Denshi Co., Ltd
12.1.8. Johnson & Johnson Services, Inc.
12.1.9. Koninklijke Philips N.V.
12.1.10. LivaNova PLC
12.1.11. Medtronic PLC
12.1.12. Nihon Kohden Corporation
12.1.13. Novartis International AG
12.1.14. Pfizer Inc.
12.1.15. Stryker Corporation
12.1.16. ZOLL Medical Corporation
12.2. Key Product Portfolio
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. CARDIAC ARREST TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. CARDIAC ARREST TREATMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. CARDIAC ARREST TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. CARDIAC ARREST TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. CARDIAC ARREST TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CARDIAC ARREST TREATMENT MARKET DYNAMICS
FIGURE 7. CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
FIGURE 8. CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 10. CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS CARDIAC ARREST TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS CARDIAC ARREST TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES CARDIAC ARREST TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES CARDIAC ARREST TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC CARDIAC ARREST TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC CARDIAC ARREST TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. CARDIAC ARREST TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. CARDIAC ARREST TREATMENT MARKET SHARE, BY KEY PLAYER, 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Amgen Inc.
  • Bayer AG
  • BIOTRONIK SE & CO., KG
  • Boston Scientific Corporation
  • Bristol-Myers Squibb Company
  • Fukuda Denshi Co., Ltd
  • Johnson & Johnson Services, Inc.
  • Koninklijke Philips N.V.
  • LivaNova PLC
  • Medtronic PLC
  • Nihon Kohden Corporation
  • Novartis International AG
  • Pfizer Inc.
  • Stryker Corporation
  • ZOLL Medical Corporation

Methodology

Loading
LOADING...

Table Information